FMB
AMED

Field & Main Bank’s Amedisys AMED Stock Holding History

Field & Main Bank’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-440
Closed -$43K – 271
2022
Q3 		$43K Sell
440
-225
-34% -$26.8K 0.03% 174
2022
Q2 		$70K Buy
665
+100
+18% +$12.8K 0.05% 155
2022
Q1 		$97K Sell
565
-40
-7% -$5.98K 0.06% 137
2021
Q4 		$98K Buy
605
+475
+365% +$76.3K 0.06% 141
2021
Q3 		$19K Buy
+130
New +$27K 0.01% 180

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Field & Main Bank's AMED Position: Q4 2022 in Review

Field & Main Bank sold out of Amedisys (AMED) in Q4 2022, closing a stake of 440 shares — an estimated $43K sold.

Field & Main Bank first reported a position in AMED in Q3 2021 and held it in 5 quarters. The position peaked at $98K in Q4 2021. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Field & Main Bank reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Field & Main Bank sold 440 Amedisys shares in Q4 2022, an estimated $43K.
  • Field & Main Bank first reported a position in Amedisys in Q3 2021 and held it in 5 quarters.
  • Field & Main Bank's Amedisys position peaked at $98K in Q4 2021.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Field & Main Bank's 13F filing for Q4 2022, filed 19 Jan 2023.